Location · Boston, MA
Clinical trials in Boston, MA
787 recruiting studies have a site in the Boston area, and 318 of them accept healthy volunteers. The area includes Cambridge, Brookline, Newton, Waltham, Burlington, Chestnut Hill and nearby cities.
787 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc.
- Location
- Scottsdale, AZ + 8 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Phoenix, AZ + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ansun Biopharma, Inc.
- Location
- Duarte, CA + 18 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Huntsville, AL + 29 other US sites
- Eligibility basics
- Ages 50–80
- Recruiting
Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
Amplifi Vascular, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
Medtronic - MITG
- Location
- New Haven, CT + 5 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Sanofi
- Location
- Clovis, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Global Trial in APG2575 for Patients With CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Tuscon, AZ + 10 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Syndax Pharmaceuticals
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 2+
- Recruiting
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
ONWARD Medical, Inc.
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Radiation Free Study
Philips Clinical & Medical Affairs Global
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Phoenix, AZ + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Tiziana Life Sciences LTD
- Location
- Boston, MA
- Eligibility basics
- Ages 30–85
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Birmingham, AL + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Monument Therapeutics Limited
- Location
- Irvine, CA + 14 other US sites
- Eligibility basics
- Ages 17–30
- RecruitingPhase 3
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals
- Location
- Dothan, AL + 18 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
Flo Digital Contraceptive Study
Flo Health Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 18+ · Women only
- Recruiting
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
SterileCare Inc.
- Location
- Boston, MA + 6 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Nkarta, Inc.
- Location
- Little Rock, AR + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Ardelyx
- Location
- Foley, AL + 108 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Rapamycin Holdings Inc.
- Location
- Arcadia, CA + 17 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Sangamo Therapeutics
- Location
- Scottsdale, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Life Biosciences Inc.
- Location
- Glendale, CA + 3 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Kodiak Sciences Inc
- Location
- Phoenix, AZ + 47 other US sites
- Eligibility basics
- Ages 18+